Xuezhong Cai
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Oncology top 5%
- Epidemiology top 10%
- Immunology top 10%
- Co-authors
- Bryan R. CullenCurt H. HagedornShihua LuCarlos GonzálezZhihong ZhangBlossom DamaniaJohn P. BilelloRonald C. Desrosiers
- Topics
- MicroRNA in disease regulation (7 papers)Viral-associated cancers and disorders (5 papers)Extracellular vesicles in disease (4 papers)
- Partner nations
- United StatesChina
In The Last Decade
Xuezhong Cai
14 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Molecular Biology 2.5k
- Cancer Research 2.4k
- Oncology 630
- Epidemiology 465
- Immunology 294
Countries citing papers authored by Xuezhong Cai
This map shows the geographic impact of Xuezhong Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuezhong Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuezhong Cai more than expected).
Fields of papers citing papers by Xuezhong Cai
This network shows the impact of papers produced by Xuezhong Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuezhong Cai. The network helps show where Xuezhong Cai may publish in the future.
Co-authorship network of co-authors of Xuezhong Cai
This figure shows the co-authorship network connecting the top 25 collaborators of Xuezhong Cai. A scholar is included among the top collaborators of Xuezhong Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuezhong Cai. Xuezhong Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 161 | |
| 3 | 47 | |
| 4 | The imprinted H19 noncoding RNA is a primary microRNA precursorbreakdown → | 505 |
| 5 | 437 | |
| 6 | 115 | |
| 7 | 56 | |
| 8 | 99 | |
| 9 | 91 | |
| 10 | 474 | |
| 11 | Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAsbreakdown → | 1375 |
| 12 | 7 | |
| 13 | 6 | |
| 14 | Cloning of Schistosoma japonicum Chinese Strain TPI Gene and Characterization of Its Expression Product in Escherichia coli. | 1 |
About Xuezhong Cai
Xuezhong Cai is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 14 papers that have together received 3.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Viral-associated cancers and disorders (5 papers) and Extracellular vesicles in disease (4 papers). The work is most often cited by research in Cancer Research (2.4k citations), Molecular Biology (2.5k citations) and Oncology (630 citations). Xuezhong Cai has collaborated with scholars based in United States and China. Frequent co-authors include Bryan R. Cullen, Curt H. Hagedorn, Shihua Lu, Carlos González, Zhihong Zhang, Blossom Damania, John P. Bilello, Ronald C. Desrosiers, Alexandra Schäfer and Rachel Hood Edwards. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular Cell and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.